Comparing Different Methods for the Diagnosis of Liver Steatosis: What Are the Best Diagnostic Tools?

99mTc MIBI CARS microscopy MCD diet MR spectroscopy liver steatosis near-infrared spectroscopy

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
16 Oct 2024
Historique:
received: 13 08 2024
revised: 07 10 2024
accepted: 09 10 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

Due to the ongoing organ shortage, marginal grafts with steatosis are more frequently used in liver transplantation, leading to higher occurrences of graft dysfunction. A histological analysis is the gold standard for the quantification of liver steatosis (LS), but has its drawbacks: it is an invasive method that varies from one pathologist to another and is not available in every hospital at the time of organ procurement. This study aimed to compare non-invasive diagnostic tools to a histological analysis for the quantification of liver steatosis. Male C57BL6J mice were fed with a methioninecholine-deficient (MCD) diet for 14 days or 28 days to induce LS, and were compared to a control group of animals fed with a normal diet. The following non-invasive techniques were performed and compared to the histological quantification of liver steatosis: magnetic resonance spectroscopy (MRS), CARS microscopy, After 28 days on the MCD diet, an evaluation of LS showed ≥30% macrovesicular steatosis. High correlations were found between the NIR-SG1 and the blinded pathologist analysis (R The best-performing non-invasive methods for LS quantification are MRS, CARS microscopy, and the NIR-SG1. The NIR-SG1 is particularly appropriate for clinical practice and needs to be validated by clinical studies on liver grafts.

Sections du résumé

BACKGROUND BACKGROUND
Due to the ongoing organ shortage, marginal grafts with steatosis are more frequently used in liver transplantation, leading to higher occurrences of graft dysfunction. A histological analysis is the gold standard for the quantification of liver steatosis (LS), but has its drawbacks: it is an invasive method that varies from one pathologist to another and is not available in every hospital at the time of organ procurement. This study aimed to compare non-invasive diagnostic tools to a histological analysis for the quantification of liver steatosis.
METHODS METHODS
Male C57BL6J mice were fed with a methioninecholine-deficient (MCD) diet for 14 days or 28 days to induce LS, and were compared to a control group of animals fed with a normal diet. The following non-invasive techniques were performed and compared to the histological quantification of liver steatosis: magnetic resonance spectroscopy (MRS), CARS microscopy,
RESULTS RESULTS
After 28 days on the MCD diet, an evaluation of LS showed ≥30% macrovesicular steatosis. High correlations were found between the NIR-SG1 and the blinded pathologist analysis (R
CONCLUSIONS CONCLUSIONS
The best-performing non-invasive methods for LS quantification are MRS, CARS microscopy, and the NIR-SG1. The NIR-SG1 is particularly appropriate for clinical practice and needs to be validated by clinical studies on liver grafts.

Identifiants

pubmed: 39451615
pii: diagnostics14202292
doi: 10.3390/diagnostics14202292
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Sophie Chopinet (S)

Department of Digestive Surgery and Liver Transplantation, Hôpital la Timone, AP-HM, 13005 Marseille, France.
Aix Marseille Université, LIIE, 13007 Marseille, France.
Aix Marseille Université, CERIMED, 13007 Marseille, France.

Olivier Lopez (O)

Aix Marseille Université, LIIE, 13007 Marseille, France.
Aix Marseille Université, CERIMED, 13007 Marseille, France.
Department of Digestive and Oncologic Radiology, Hôpital l'Archet 2, 06202 Nice, France.

Sophie Brustlein (S)

Aix Marseille Université, CERIMED, 13007 Marseille, France.

Antoine Uzel (A)

INSA-Lyon, Université Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR5220, U1294, 69616 Lyon, France.

Anais Moyon (A)

C2VN, INSERM 1263 INRAE 1260, Aix-Marseille Université, 13007 Marseille, France.
Department of Radiopharmacy, Hôpital la Timone, AP-HM, 13007 Marseille, France.

Isabelle Varlet (I)

Aix-Marseille Université, CNRS, CRMBM, 13007 Marseille, France.

Laure Balasse (L)

Aix Marseille Université, CERIMED, 13007 Marseille, France.

Frank Kober (F)

Aix-Marseille Université, CNRS, CRMBM, 13007 Marseille, France.

Mickaël Bobot (M)

Aix Marseille Université, CERIMED, 13007 Marseille, France.
C2VN, INSERM 1263 INRAE 1260, Aix-Marseille Université, 13007 Marseille, France.
Center of Nephrology and Kidney Transplantation, Hôpital de la Conception, AP-HM, 13005 Marseille, France.

Monique Bernard (M)

Aix-Marseille Université, CNRS, CRMBM, 13007 Marseille, France.

Aurélie Haffner (A)

Department of Anatomopathology, Hôpital la Timone, AP-HM, 13007 Marseille, France.

Michaël Sdika (M)

INSA-Lyon, Université Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR5220, U1294, 69616 Lyon, France.

Bruno Montcel (B)

INSA-Lyon, Université Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR5220, U1294, 69616 Lyon, France.

Benjamin Guillet (B)

Aix Marseille Université, CERIMED, 13007 Marseille, France.
C2VN, INSERM 1263 INRAE 1260, Aix-Marseille Université, 13007 Marseille, France.
Department of Radiopharmacy, Hôpital la Timone, AP-HM, 13007 Marseille, France.

Vincent Vidal (V)

Aix Marseille Université, LIIE, 13007 Marseille, France.
Aix Marseille Université, CERIMED, 13007 Marseille, France.
Aix-Marseille Université, 27 Boulevard Jean Moulin, 13385 Marseille, France.

Emilie Grégoire (E)

Aix Marseille Université, LIIE, 13007 Marseille, France.
Aix Marseille Université, CERIMED, 13007 Marseille, France.

Jean Hardwigsen (J)

Department of Digestive Surgery and Liver Transplantation, Hôpital la Timone, AP-HM, 13005 Marseille, France.
Aix-Marseille Université, 27 Boulevard Jean Moulin, 13385 Marseille, France.

Pauline Brige (P)

Aix Marseille Université, LIIE, 13007 Marseille, France.
Aix Marseille Université, CERIMED, 13007 Marseille, France.

Classifications MeSH